Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
110.01
+0.72 (+0.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Jazz Pharma Plc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
3 Biotech Stocks You’ll Regret Not Buying Soon
August 08, 2023
These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
Via
Benzinga
GOP Rep. Blasts FDA Over CBD Inaction During Historic Hearing: The Agency Wants More Money To Do Its Job
July 28, 2023
For the first time, Congress officially addressed the impact of the U.S. Food and Drug Administration’s (FDA) inaction regarding the regulations of CBD products.
Via
Benzinga
FDA, Get It Done! Says Senator In Bipartisan Push To Regulate CBD Products Prior To Committee Hearing
July 21, 2023
A bipartisan group of U.S. lawmakers reintroduceda measure on Wednesdaythat aims to secure theFood and Drug ...
Via
Benzinga
Where Jazz Pharmaceuticals Stands With Analysts
July 11, 2023
Via
Benzinga
Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group
July 10, 2023
Is the battle for medical marijuana legalization in North Carolina over for this year? Some groups say yes, some say know, here is what happened.
Via
Benzinga
Is Axsome Therapeutics Stock a Screaming Buy?
June 15, 2023
The biotech could be staring down an enormous commercial opportunity.
Via
The Motley Fool
Expert Ratings for Jazz Pharmaceuticals
June 05, 2023
Via
Benzinga
4 Unequaled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
July 08, 2023
Bargains are hiding in plain sight with the Nasdaq Composite still well below its November 2021 record-closing high.
Via
The Motley Fool
Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful'
June 23, 2023
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has filed suit against the FDA for approving Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) Lumryz (sodium oxybate extended-release) for cataplexy or excessive day
Via
Benzinga
10 Cannabis Stocks That Could Go Sky High In 2023
June 18, 2023
With cannabis legalization gaining momentum, investing in cannabis presents a lucrative opportunity. Investors may want to explore cannabis stocks to enhance their portfolios. Here are the top 10...
Via
Talk Markets
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
Stocks That Hit 52-Week Lows On Tuesday
June 13, 2023
On Tuesday, 32 companies reached new 52-week lows.
Via
Benzinga
Where Jazz Pharmaceuticals Stands With Analysts
May 15, 2023
Via
Benzinga
3 Cheap Growth Stocks That Are Too Good to Pass Up
June 05, 2023
These top bargain growth stocks are all priced under $10 a share and offer real upside potential for investors.
Via
InvestorPlace
FDA Presents Potential Framework For CBD, From Edibles To Delta-8, Reaffirms Congress Is In Charge
May 30, 2023
The U.S. Food and Drug Administration has not given up on regulating CBD and hemp-derived products in a way that would be safe for consumers and producers.
Via
Benzinga
Ford To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Tuesday
May 30, 2023
Keybanc boosted the price target for Broadcom Inc. (NASDAQ: AVGO) from $720 to $820. Keybanc analyst John Vinh maintained the stock with an Overweight rating. Broadcom shares rose 11.5% to close at...
Via
Benzinga
Jazz Pharmaceuticals Analysis Reveals THC And CBD Therapy Alleviates MS Spasticity
May 25, 2023
Treatment with the cannabis-based oral spray Nabiximols has been found to significantly relieve spasticity, a common symptom of multiple sclerosis (MS), according to a new analysis of two MS clinical...
Via
Benzinga
Recap: Jazz Pharmaceuticals Q1 Earnings
May 10, 2023
Via
Benzinga
Why Avadel Pharma Shares Are Gaining Today
May 01, 2023
Via
Benzinga
World-First Clinical Trial Using Cannabis-Based Drug To Treat Deadly Brain Tumors Recruits First Patients
May 25, 2023
Can a cannabis-based medicine help treat aggressive brain tumors? Scientists in the UK are getting closer to answering that question. Ongoing lab research is about to become real-world as the project...
Via
Benzinga
Jazz Pharma Q1 FY23 Revenue Grows 10% YoY, What About Net Income?
May 11, 2023
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) released financial results for the first quarter of 2023, revealing revenue of $892.8 million, an increase of 10% compared to $813.7 million in Q1 2022.
Via
Benzinga
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
May 09, 2023
The biotech's share price more than doubled during last year's bear market.
Via
The Motley Fool
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
May 09, 2023
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope...
Via
Talk Markets
Pressure BioScience's Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux
May 09, 2023
Often considered recession-proof, the life sciences sector faced a surprising amount of uncertainty over the past few years with up to 80% of companies saying they’ve been negatively impacted by the...
Via
Benzinga
Why Shares of Avadel Soared This Week
May 05, 2023
The company got its first FDA approval.
Via
The Motley Fool
If You Invested $5,000 in Axsome Therapeutics 5 Years Ago, Here's How Much You Would Have Now
April 25, 2023
Axsome's new products have blockbuster potential.
Via
The Motley Fool
The Top Healthcare Stocks to Buy With $100
April 18, 2023
A small investment now may bring big results over time.
Via
The Motley Fool
2 Top Biotech Stocks to Buy in April
April 04, 2023
Right now you can pick up these stocks on the dip.
Via
The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
March 29, 2023
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.